Login
Login
切换导航
Home
Articles
Journals
Books
News
About
Services
Submit
Home
Journals
Articles
Journals Menu
Aims & Scope
Articles
Archive
Editorial Board
Publication Fees
Indexing
Guidelines & Policies
Author Guidelines
Reviewer Guidelines
Editorial Policies
Publication Ethics
Follow SCIRP
Contact us
[email protected]
+86 18163351462
(WhatsApp)
1655362766
SCIRP WeChat
Journal of Cancer Therapy
Submission
Journal of Cancer Therapy
ISSN Print:
2151-1934
ISSN Online:
2151-1942
www.scirp.net/journal/jct
E-mail:
[email protected]
Citations
Journals Menu
Aims & Scope
Articles
Archive
Editorial Board
Publication Fees
Indexing
Guidelines & Policies
Author Guidelines
Reviewer Guidelines
Editorial Policies
Publication Ethics
Cancer: Tumor Iron Metabolism, Mitochondrial Dysfunction and Tumor Immunosuppression; “A Tight Partnership—Was Warburg Correct?”
()
Robert L. Elliott
,
Jonathan F. Head
Journal of Cancer Therapy
Vol.3 No.4
, August 9, 2012
DOI:
10.4236/jct.2012.34039
8,495
Downloads
15,797
Views
Citations
This article belongs to the Special Issue on
Induction of Human Anti-Human Antibody Responses (Ab2) after Application of a Humanized Lewis Y Carbohydrate Specific Antibody (Ab1): Connection of Prolonged Disease Stabilization with Ab3 Induction?
()
Andreas Nechansky
,
Stefan Stranner
,
Oliver Scheiber
,
Nicole Halanek
,
Ralf Kircheis
Journal of Cancer Therapy
Vol.3 No.4
, August 9, 2012
DOI:
10.4236/jct.2012.34038
4,286
Downloads
7,474
Views
Citations
This article belongs to the Special Issue on
Oral Squamous Cell Carcinoma: Epidemiology, Clinical Presentation and Treatment
()
Liviu Feller
,
Johan Lemmer
Journal of Cancer Therapy
Vol.3 No.4
, August 9, 2012
DOI:
10.4236/jct.2012.34037
22,822
Downloads
43,346
Views
Citations
This article belongs to the Special Issue on
Treatment of Incidental Prostate Cancer Diagnosed during BPH Surgery with Radical Prostatectomy: Appropriate or over Treatment?
()
Adnan Simsir
,
Bulent Akdogan
,
Cag Cal
,
Sumer Baltaci
,
Haluk Ozen
Journal of Cancer Therapy
Vol.3 No.4
, August 9, 2012
DOI:
10.4236/jct.2012.34036
4,708
Downloads
7,909
Views
Citations
This article belongs to the Special Issue on
Preclinical Efficacy of Nimotuzumab, an Anti-Egfr Monoclonal Antibody as a Single Agent Therapy in Human GBM u87mg Xenografts
()
Arlhee Diaz
,
Rances Blanco
,
Margit Lemm
,
Iduna Fichtner
,
Kalet Leon
,
Enrique Montero
Journal of Cancer Therapy
Vol.3 No.4
, August 9, 2012
DOI:
10.4236/jct.2012.34035
4,715
Downloads
8,707
Views
Citations
This article belongs to the Special Issue on
Antitumor Effect of Cationic INKKI Peptide from Bovine
β
-Casein on Melanoma B16F10
()
Ricardo Alexandre Azevedo
,
Adilson Kleber Ferreira
,
Aline Vivian Vatti Auada
,
Kerly Fernanda Mesquita Pasqualoto
,
Rafael Marques-Porto
,
Durvanei Augusto Maria
,
Ivo Lebrun
Journal of Cancer Therapy
Vol.3 No.4
, August 9, 2012
DOI:
10.4236/jct.2012.34034
4,421
Downloads
7,854
Views
Citations
This article belongs to the Special Issue on
Pharmacological Isolation of Experimental Models of Drug-resistant Hepatocellular Carcinoma Cell Line
()
Benedict Onyekachi Odii
,
Peter Coussons
Journal of Cancer Therapy
Vol.3 No.4
, August 9, 2012
DOI:
10.4236/jct.2012.34031
4,983
Downloads
9,773
Views
Citations
This article belongs to the Special Issue on
<
...
193
194
195
...
>
Page
Special Issues
Open Special Issues
Published Special Issues
Special Issues Guideline
Most Cited
Most Downloaded
Newsletter
Order Print Copy
Contact Us
FAQ
Disclaimer
History Issue
Special Issues
Open Special Issues
Published Special Issues
Special Issues Guideline
Follow SCIRP
Contact us
[email protected]
+86 18163351462(WhatsApp)
1655362766
Paper Publishing WeChat
SCIRP Newsletter
Home
Journals A-Z
Subject
Books
Sitemap
Contact Us
News
About SCIRP
Ethics
Editorial Policies
For Authors
Peer-Review Issues
Publication Fees
Special Issues
Service
Manuscript Tracking System
Order Print Copies
Translation & Proofreading
FAQ
Volume & Issue
Policies
Open Access
Publication Ethics
Preservation
Retraction
Privacy Policy
Copyright © 2006-2026 Scientific Research Publishing Inc. All Rights Reserved.
Top